Fludocyte 50mg Injection
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Fludarabine (50mg)
Overview Fludocyte 50mg Injection
Leukemia treatment with the injectable medication, Fludarabine 50mg, is indicated for chronic lymphocytic leukemia (CLL). Its application may extend to other conditions as directed by a physician, potentially as part of a multi-drug chemotherapy regimen. Administered intravenously under medical supervision, the dosage and frequency are determined by the treating physician, varying with the specific condition and potentially adjusted over time. Precise adherence to the prescribed regimen is crucial; deviations can lead to severe adverse reactions. While therapeutic effects may not be immediately apparent, discontinuation is only permissible under physician guidance. Common side effects encompass nausea, emesis, diarrhea, cephalalgia, asthenia, pyrexia, and cough. A reduction in blood cell counts (leukopenia and anemia), heightening infection risk, is possible; regular blood monitoring, including hematological, cardiac, hepatic, and uric acid assessments, is essential. Prior to commencing treatment, disclose any pre-existing cardiac, hepatic, or renal conditions, as well as all concurrent medications (including anti-infectives), to your doctor. Numerous drug interactions are possible. Use during gestation or lactation is contraindicated; reliable contraception for both partners is mandatory throughout treatment.
Primary Ingredients of Fludocyte 50mg Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Fludocyte 50mg Injection
Chronic lymphocytic leukemia, a type of blood malignancy
Major Benefits of Fludocyte 50mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Fludocyte 50mg Injection:
- Increased risk of infection
- Vomiting
- Weakness
- Nausea
- Fatigue
- Fever
- Decreased blood cells (red cells, white cells, and platelets)
- Diarrhea
- Cough
How to use Fludocyte 50mg Injection:
This medication will be administered by your physician or their qualified staff. Self-medication is strictly prohibited.
How Fludocyte 50mg Injection works:
Fludocyte 50mg Injection is a cancer treatment that inhibits the replication of cancerous cells' DNA and RNA within the bloodstream. This action restricts tumor growth and ultimately leads to cell death.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Fludocyte 50mg Injection may pose safety risks; physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Administering Fludocyte 50mg Injection during pregnancy carries confirmed risks to fetal development and is therefore contraindicated. Nevertheless, in exceptional, life-threatening circumstances, a physician might deem its use necessary if the potential advantages outweigh the hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Fludocyte 50mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administration of Fludocyte 50mg Injection may induce adverse reactions impacting driving capabilities. Fatigue, weakness, visual disturbances, confusion, agitation, and seizures have been reported in some patients receiving Fludocyte 50mg Injection, potentially compromising safe driving.
KidneyCAUTION
Exercise caution when administering Fludocyte 50mg Injection to individuals with impaired renal function; dosage modification may be necessary. Consult a physician before use. Fludocyte 50mg Injection is contraindicated in patients exhibiting severe kidney disease.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Fludocyte 50mg Injection. Dosage modification of Fludocyte 50mg Injection may be necessary. Physician consultation is advised.
What if you forget to take Fludocyte 50mg Injection :
NA
Facts to Know About Fludocyte 50mg Injection
| Label | Value |
|---|---|
| Chemical Type | Purine Nucleoside Analogs |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Action Category | Metabolic Inhibitors |
3,018 People bought this recently